Market capitalization | $168.73m |
Enterprise Value | $-880.47m |
EV/Sales (TTM) EV/Sales | -4.54 |
P/S ratio (TTM) P/S ratio | 0.87 |
Short interest | 2.08% |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
1 Analyst has issued a forecast Global Cord Blood Corporation:
1 Analyst has issued a forecast Global Cord Blood Corporation:
Mar '22 |
+/-
%
|
||
Revenue | 194 194 |
13%
13%
|
|
Gross Profit | 163 163 |
14%
14%
|
|
EBITDA | 103 103 |
17%
17%
|
EBIT (Operating Income) EBIT | 95 95 |
18%
18%
|
Net Profit | 78 78 |
4%
4%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. It preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.
Head office | Cayman Islands |
CEO | Ting Zheng |
Founded | 2008 |
Website | www.globalcordbloodcorporation.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.